Business Avicanna files patent for cannabinoid med that reduces epileptic seizures, sudden death A number of the medical cannabis maker's products are available to Canadian patients Natalia Buendia CalvilloSeptember 24, 2021
Industry update GW Pharma shares soar 21% on rising revenues The cannabinoid drugmaker also launched a Phase 3 trial for a multiple sclerosis treatment Jared GnamNovember 3, 2020
Medical and Pharmaceutical GW Pharma asks FDA to approve Epidiolex to treat a third epileptic disorder The cannabis-based medicine could treat seizures associated with Tuberous Sclerosis Complex Michelle GamageFebruary 3, 2020